Finesand, based on what I learned today, I think you have realistic expectations as to what should occur in the next few months. Whether or not the FDA is supportive and CYDY's financial situation improves are significant factors that will need to fall in line. That said, from a clinical prospective, I see no impediments.
finesand- BLA, Biological License agreement and NDA, New drug application fall at the same meeting. I am very certain prior ASM knowledge of data for embargoed release for ASM today spurred CYDY early for a meeting with FDA. Approval, yes approval to manufacture and prescribe is in process as we post. Chump
News 
Market Data 
Discover 
